EU OKs First-Line Osimertinib+Chemo for EGFR+ Advanced NSCLC
The European Commission has approved Tagrisso (osimertinib; AstraZeneca) combined with pemetrexed and platinum-based chemotherapy for the first-line treatment of adult ...
Read moreDetailsThe European Commission has approved Tagrisso (osimertinib; AstraZeneca) combined with pemetrexed and platinum-based chemotherapy for the first-line treatment of adult ...
Read moreDetailsPatients with locally advanced or metastatic bladder cancer have a permanent new first-line standard of care after the FDA granted ...
Read moreDetailsMADRID -- Including pembrolizumab (Keytruda) in the first-line treatment of metastatic HER2-positive gastric or gastroesophageal cancer improved progression-free survival (PFS), ...
Read moreDetailsUpdated findings of KEYNOTE-826, presented at the American Society of Clinical Oncology (ASCO) annual meeting, continued to demonstrate a significant ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info